Reported 1 day ago
IQVIA Holdings Inc., with a market cap of $32.2 billion, is a key player in health tech, specializing in analytics and clinical research. Despite a 25.9% drop from its 52-week high, IQV shares rose 15.1% in the last three months, outperforming the Langar Global Healthtech ETF. However, year-to-date, the stock has fallen 6.4%. Following a strong Q2 report, IQV is forecasted to have an adjusted EPS between $11.75 and $12.05 for the year, maintaining a 'Strong Buy' consensus from analysts.
Source: YAHOO